Breastfeeding and the chance of gestational diabetes in the next pregnancy
Looks at whether breastfeeding relates to gestational diabetes in women who become pregnant again.
Key facts
- Who runs it
- Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
- Where
- Türkiye2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Protective Effect of Lactation Against Gestational Diabetes Mellitus in Subsequent Pregnancies: A Prospective Observational Cohort Study
- Status
- Recruiting
- People taking part
- 140 people, planned
- Started
- 15 Jan 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Record updated
- 3 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women who became pregnant while still breastfeeding. It studies whether breastfeeding lowers the risk of diabetes during pregnancy.
- Age
- 18 to 50 years
- Sex
- Women only
- Disease stage
- Pregnant with one baby (not twins or more). The pregnancy began during the breastfeeding period.
- Biomarker or test result
- Results must be available for fasting blood sugar, HbA1c, sugar in the urine and a 75-g oral glucose tolerance test (OGTT). Routine ultrasound measurements of the baby and the fluid around it must also be available.
Main reasons for not taking part
- Pregnant with twins or more babies
- Known long-term disease affecting the whole body
- Diabetes that started before the pregnancy
- Missing clinical, lab or ultrasound data
- Follow-up not at Prof. Dr. Cemil Taşcıoğlu City Hospital or Esenyurt Necmi Kadıoğlu State Hospital
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant individuals aged 18 to 50 years.
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Pregnant individuals aged 18 to 50 years
- Singleton pregnancy
- Conception during the lactation period
- Follow-up at Prof. Dr. Cemil Taşcıoğlu City Hospital or Esenyurt Necmi Kadıoğlu State Hospital
- Availability of glycemic parameters including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results
- Availability of routine ultrasonographic measurements including fetal abdominal circumference percentile (AC), estimated fetal weight percentile (EFW), and amniotic fluid index (AFI)
Who cannot take part
- Known chronic systemic disease or pre-existing diabetes mellitus
- Missing clinical, laboratory, or ultrasonographic data
- Age below 18 years
- Age above 50 years
- Multiple pregnancy
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Gestational diabetes mellitus (GDM) is a common metabolic disorder of pregnancy associated with increased maternal and fetal morbidity. Lactation has been suggested to improve maternal glucose metabolism, enhance insulin sensitivity, and reduce the risk of future glucose intolerance. However, evidence regarding the protective effect of lactation on the development of GDM in subsequent pregnancies remains limited.
Read full original descriptionShow less
This prospective observational cohort study aims to evaluate the association between lactation and the risk of gestational diabetes mellitus and related pregnancy complications in women who conceive during the lactation period. Routine glycemic markers including fasting plasma glucose, HbA1c, glycosuria, and 75-g oral glucose tolerance test (OGTT) results will be recorded. Ultrasonographic findings including fetal abdominal circumference percentile, estimated fetal weight percentile, and amniotic fluid index will also be assessed. The study will investigate whether lactation is associated with a reduced risk of GDM, fetal macrosomia, and polyhydramnios in subsequent pregnancies.
The group in the trial
- Pregnant Women During Lactation Period
Singleton pregnant women aged 18-50 years who conceived during the lactation period and were followed at participating obstetrics and gynecology clinics.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Protective Effect of Lactation Against Gestational Diabetes Mellitus in Subsequent Pregnancy: A Prospective Observational Cohort Study
- Plain-language title
- Breastfeeding and the chance of gestational diabetes in the next pregnancyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07624968, who can take part
- Record updated
- 3 June 2026